Patent USRE39587E1 successfully refreshed from Google Patents.
USRE39587E1
Expired / Lapsed
US
⏱️ 0.0 years remaining
Malleable paste for filling bone defects
Assignee: Musculoskeletal Transplant Foundation
•
Filing: 2004-05-12
•
Granted: 2007-04-24
•
Expires: 2024-05-12
Abstract
Abstract The invention is directed toward a malleable bone putty and a flowable gel composition for application to a bone defect site to promote new bone growth at the site which comprises a new bone growth inducing compound of demineralized lyophilized allograft bone powder. The bone powder has a particle size ranging from about 100 to about 850 microns and is mixed in a high molecular weight hydrogel carrier, the hydrogel component of the carrier ranging from about 0.3 to 3.0% of the composition and having a molecular weight of about at least 10,000 Daltons. The composition contains about 25% to about 40% bone powder and can be additionally provided with BMP's and a sodium phosphate buffer.
Inventors
- 👤 Arthur A. Gertzman
- 👤 Moon Hae Sunwoo
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 20:49
CPC Classifications
A; A61; A61L; A61L27/00; A61L27/36; A61L27/3683; A61L27/3691; A61K; A61K35/00; A61K35/12; A61K35/32; A61K38/00; A61K38/16; A61K38/17; A61K38/18; A61K38/1875; A61L24/00; A61L24/0005; A61L24/001; A61L24/0031; A61L24/0047; A61L24/0073; A61L24/0094; A61L27/3604; A61L27/3608; A61L27/3641; A61L27/3645; A61L27/365; A61L27/40; A61L27/44; A61L27/48; A61L27/50; A61L27/52; C; C08; C08L; C08L5/00; C08L5/08; A61F; A61F2/00; A61F2/02; A61F2/28; A61F2/30; A61F2002/30001; A61F2002/30003; A61F2002/30004; A61F2002/30059; A61L2430/00; A61L2430/02
Claims Analysis
Total Claims: 36
Claim 1
Independent Claim
107 words
A sterile malleable bone composition for application to a bone defect site to promote new bone growth at the site comprising a mixture of demineralized osteogenic osteoinductive bone powder with a particle size ranging from about 100 to about 850 microns in a carrier, the bone powder ranging from about 25 to about 35% of the weight of the composition, the carrier is selected from the group consisting of sodium hyaluronate, chitosan and consisting of N,O-carboxymethylchitosan in water solution having a high molecular weight ranging from five hundred thousand to three million Daltons and ranging from about 1.0% to about 3.0% by weight of the carrier solution.
Claim 2
Dependent Claim
107 words
A sterile malleable bone composition for application to a bone defect site to promote new bone growth at the site comprising a mixture of demineralized osteogenic osteoinductive bone powder with a particle size ranging from about 100 to about 850 microns in a carrier, the bone powder ranging from about 25 to about 35% of the weight of the composition, the carrier is selected from the group consisting of sodium hyaluronate, chitosan and consisting of N,O-carboxymethylchitosan in water solution having a high molecular weight ranging from five hundred thousand to three million Daltons and ranging from about 1.0% to about 3.0% by weight of the carrier solution.
Claim 3
Dependent Claim
28 words
A sterile malleable bone composition as claimed in claim 1 wherein said mixture includes bone morphogenic proteins in excess of the amount naturally occurring in allergenic allogenic bone.
Claim 4
Dependent Claim
20 words
A sterile malleable bone composition as claimed in claim 1 including the addition of a calcium salt to the carrier.
Claim 5
Dependent Claim
29 words
A sterile malleable bone composition as claimed in claim 1 wherein the balance of the carrier formulation contains a sodium phosphate buffer and having a pH of about 7.2.
Claim 6
Dependent Claim
19 words
A sterile malleable bone composition as claimed in claim 1 wherein said bone powder is cortical allograft bone powder.
Claim 7
Dependent Claim
19 words
A sterile malleable bone composition as claimed in claim 1 wherein said bone powder is corticocancellous allograft bone powder.
Claim 8
Dependent Claim
109 words
A sterile malleable bone putty composition for application to a bone defect site to promote new bone growth at the site which comprises a new bone growth inducing mixture of demineralized lyophilized allograft bone powder with a particle size ranging from about 100 to about 850 microns in a hyaluronic acid water carrier, the hyaluronic acid component ranging from above 1.0% to about 3% of the carrier solution and having a molecular weight of at least 10 6 Daltons and a viscosity ranging from 6,000 to about 275,000 cps, the bone content of the carrier ranging in weight from about 25% to about 35% total weight of the composition.
Claim 9
Dependent Claim
109 words
A sterile malleable bone putty composition for application to a bone defect site to promote new bone growth at the site which comprises a new bone growth inducing mixture of demineralized lyophilized allograft bone powder with a particle size ranging from about 100 to about 850 microns in a hyaluronic acid water carrier, the hyaluronic acid component ranging from above 1.0% to about 3% of the carrier solution and having a molecular weight of at least 10 6 Daltons and a viscosity ranging from 6,000 to about 275,000 cps, the bone content of the carrier ranging in weight from about 25% to about 35% total weight of the composition.
Claim 10
Dependent Claim
22 words
A malleable bone putty composition as claimed in claim 7 including the addition of a calcium salt to the hyaluronic acid carrier.
Claim 11
Dependent Claim
17 words
A malleable bone putty composition as claimed in claim 8 wherein said calcium salt is calcium chloride.
Claim 12
Dependent Claim
17 words
A malleable bone putty composition as claimed in claim 8 wherein said calcium salt is calcium sulfate.
Claim 13
Dependent Claim
17 words
A malleable bone putty composition as claimed in claim 8 wherein said calcium salt is calcium phosphate.
Claim 14
Dependent Claim
17 words
A malleable bone putty composition as claimed in claim 8 wherein said calcium salt is calcium hydroxyapatite.
Claim 15
Dependent Claim
29 words
A malleable bone putty composition as claimed in claim 7 wherein said carrier has a 2-3% hyaluronic acid concentration with the balance of the carrier formulation comprising saline water.
Claim 16
Dependent Claim
29 words
A malleable bone putty composition as claimed in claim 7 wherein said carrier has a 2-3% hyaluronic acid concentration with the balance of the carrier formulation comprising sterile water.
Claim 17
Dependent Claim
50 words
A malleable bone putty composition as claimed in claim 7 wherein said hydrogel carrier has a 2-3% hyaluronic acid concentration with the balance of the carrier formulation contains a sodium phosphate buffer with a pH of about 7.2, said buffer attracting calcium and concentrating same at the bone defect site.
Claim 18
Dependent Claim
25 words
A malleable bone putty composition as claimed in claim 7 wherein said carrier includes BMP in excess of the amount naturally occurring in allergenic bone.
Claim 19
Dependent Claim
19 words
A malleable bone putty composition as claimed in claim 7 wherein said bone powder is cortical allograft bone powder.
Claim 20
Dependent Claim
16 words
A malleable bone putty composition as claimed in claim 7 wherein said bone powder is corticocancellous.
Claim 21
Dependent Claim
34 words
A malleable bone putty composition as claimed in claim 7 including antimicrobial and/or antibiotics such as erythromycin, bacitracin, neomycin, penicillin, polymyxin B, tetracycline, viomycin, chloromycetin and streptomycin, cefazolin, ampicillin, azactam, tobramycin, clindamycin and gentamycin.
Claim 22
Dependent Claim
12 words
A malleable bone putty composition as claimed in claim 7 including vitamins.
Claim 23
Dependent Claim
18 words
A malleable bone putty composition as claimed in claim 7 including enzymes such as collagenase, peptidases and oxidases.
Claim 24
Dependent Claim
96 words
A malleable bone putty composition for application to a bone defect site to promote new bone growth at the site comprising a new bone growth inducing demineralized lyophilized allograft bone powder with a particle size ranging from about 100 to about 420 microns in a high molecular weight sodium hyaluronate and water carrier, the bone content of the composition ranging from about 30% to about 35% by weight and the high molecular weight sodium hyaluronate component ranges from about 2% to about 3% of the carrier and has a molecular weight greater than one million Daltons.
Claim 25
Dependent Claim
96 words
A malleable bone putty composition for application to a bone defect site to promote new bone growth at the site comprising a new bone growth inducing demineralized lyophilized allograft bone powder with a particle size ranging from about 100 to about 420 microns in a high molecular weight sodium hyaluronate and water carrier, the bone content of the composition ranging from about 30% to about 35% by weight and the high molecular weight sodium hyaluronate component ranges from about 2% to about 3% of the carrier and has a molecular weight greater than one million Daltons.
Claim 26
Dependent Claim
79 words
A sterile malleable bone putty composition for application to a bone defect site to promote new bone growth at the site which comprises a new bone growth inducing compound of demineralized lyophilized allograft bone powder with a particle size, ranging from about 100 to about 420 microns in a N,O-carboxymethylchitosan water carrier solution, the N,O-carboxymethylchitosan component ranging from about 1.0% to about 3% of the carrier weight and having a molecular weight ranging from 2.0×10 6 −3.0×10 6 Daltons.
Claim 27
Dependent Claim
79 words
A sterile malleable bone putty composition for application to a bone defect site to promote new bone growth at the site which comprises a new bone growth inducing compound of demineralized lyophilized allograft bone powder with a particle size, ranging from about 100 to about 420 microns in a N,O-carboxymethylchitosan water carrier solution, the N,O-carboxymethylchitosan component ranging from about 1.0% to about 3% of the carrier weight and having a molecular weight ranging from 2.0×10 6 −3.0×10 6 Daltons.
Claim 28
Dependent Claim
95 words
A malleable bone putty composition for application to a bone defect site to promote new bone growth at the site which comprises a new bone growth inducing demineralized lyophilized allograft bone powder with a particle size ranging from about 100 to about 850 microns in a high molecular weight chitosan water carrier solution with the bone content of the putty composition ranging from about 30% to about 35% and the chitosan component comprising about 3% of the carrier solution with the chitosan having a molecular weight ranging from about 1.0×10 3 to 3.0×10 5 Daltons.
Claim 29
Dependent Claim
95 words
A malleable bone putty composition for application to a bone defect site to promote new bone growth at the site which comprises a new bone growth inducing demineralized lyophilized allograft bone powder with a particle size ranging from about 100 to about 850 microns in a high molecular weight chitosan water carrier solution with the bone content of the putty composition ranging from about 30% to about 35% and the chitosan component comprising about 3% of the carrier solution with the chitosan having a molecular weight ranging from about 1.0×10 3 to 3.0×10 5 Daltons.
Claim 30
Dependent Claim
23 words
A malleable bone putty composition as claimed in claim 24 wherein the carrier formulation includes a sodium phosphate buffer of about pH 7.2.
Claim 31
Dependent Claim
17 words
A malleable bone putty composition as claimed in claim 24 wherein said carrier solution includes saline water.
Claim 32
Dependent Claim
17 words
A malleable bone putty composition as claimed in claim 24 wherein said carrier solution includes sterile water.
Claim 33
Dependent Claim
90 words
A malleable bone gel composition for application to a bone defect site to promote new bone growth at the site which comprises a new bone growth inducing amount of demineralized lyophilized allograft bone powder with a particle size ranging from about 250 to about 850 microns in a high molecular weight hyaluronic acid in water carrier with the hyaluronic acid component comprising about 1% of the carrier and having a molecular weight over 1.0×10 6 Daltons, the bone powder content of the composition ranging from about 25% to about 30%.
Claim 34
Dependent Claim
90 words
A malleable bone gel composition for application to a bone defect site to promote new bone growth at the site which comprises a new bone growth inducing amount of demineralized lyophilized allograft bone powder with a particle size ranging from about 250 to about 850 microns in a high molecular weight hyaluronic acid in water carrier with the hyaluronic acid component comprising about 1% of the carrier and having a molecular weight over 1.0×10 6 Daltons, the bone powder content of the composition ranging from about 25% to about 30%.
Claim 35
Dependent Claim
99 words
A malleable bone gel composition for application to a bone defect site to promote new bone growth at the site comprising a new bone growth inducing amount of demineralized lyophilized allograft bone powder with a particle size ranging from about 250 to about 420 microns mixed in a high molecular weight hyaluronic acid water solution carrier with the hyaluronic acid component being present in the amount of about 1% of the carrier and having a viscosity of about 1,800 to 13,000 cps, the bone powder amount content of the composition ranging from about 25% to about 30% by weight.
Claim 36
Dependent Claim
99 words
A malleable bone gel composition for application to a bone defect site to promote new bone growth at the site comprising a new bone growth inducing amount of demineralized lyophilized allograft bone powder with a particle size ranging from about 250 to about 420 microns mixed in a high molecular weight hyaluronic acid water solution carrier with the hyaluronic acid component being present in the amount of about 1% of the carrier and having a viscosity of about 1,800 to 13,000 cps, the bone powder amount content of the composition ranging from about 25% to about 30% by weight.
References Cited (Backward Citations)
US2621145A
Cited
US2968593A
Cited
US4172128A
Cited
US4191747A
Cited
US4610692A
Cited
US4637931A
Cited
US4619995A
Cited
US4595713A
Cited
US5290558A
Cited
US5073373A
Cited
US5356629A
Cited
EP0522569A1
Cited
US5314476A
Cited
US5507813A
Cited
US5516532A
Cited
US5707962A
Cited
EP0784985A1
Cited
US5830493A
Cited
US6124273A
Cited
WO1998014222A1
Cited
WO1999011298A2
Cited
US6030635A
Cited
WO1999052572A1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2010-04-23 | 2010-10-23 | 2011-04-24 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2014-04-23 | 2014-10-23 | 2015-04-24 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2018-04-23 | 2018-10-23 | 2019-04-24 | $7700.00 | Window Closed / Lapsed |